BC Week In Review | Feb 9, 2017
Company News

University of South Florida, Alzamend deal

Alzamend disclosed that in May the university granted the newco exclusive, worldwide rights to a patent related to the biotech's CAO22W , a preclinical candidate for Alzheimer's disease (AD). The patent covers several mutant amyloid beta...
Items per page:
1 - 1 of 1